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Abstract
African American (AA) men have the highest incidence of prostate cancer (PCa)
compared to their White and Hispanic counterparts and a higher mortality rate than any
other ethnicity. While biological and socioeconomic factors are to be blamed, many AA
men are not aware of the opportunities for screening or the prognoses for the condition.
There is an obvious need for increased awareness in AA men concerning preventative
screening for PCa. Following the Walden University Clinical Practice Guideline Manual
and guided by the Appraisal of Guidelines for Research & Evaluation (AGREE II) model
to guide and validate the newly developed clinical practice patient education guideline
(CPPEG), an evidence-based CPPEG was developed from an in-depth review of peerreviewed literature and validated to address PCa screening in AA men. The PCa CPPEG
was scored by a panel of four content experts using the AGREE II instrument. Domain
scores ranged from 92% for Domain 6, editorial independence, to 100% for Domain 1,
scope and purpose, with all scores greater than the 75% benchmark indicating that no
revisions were needed, and a 96% agreement rate indicating that the expert panel agreed
that the PCa CPPEG should be used in the clinical setting, fulfilling the purpose and
answering the practice-focused questions. This project will bring about positive social
change through educating AA men about PCa screening and early treatment to increase
screening and decrease the mortality and morbidity of the disease.
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Section 1: Nature of the Project
The prevalence of prostate cancer (PCa) is disproportionately high in African
American (AA) men when compared to other ethnic groups in the United States. The
reasons for such disparity are still unclear, but factors to which the prevalence is
attributed include nutrition, race, family history, and lack of screening (Shenoy et al.,
2016). Screening as a preventive measure is recommended early and regularly to ensure
that early detection leads to effective treatment and recovery (Tsodikov et al., 2017);
however, the stigma surrounding PCa in the AA community, the body part that is
affected, the related embarrassment, and fear of the procedure cause barriers to
receptiveness to being screened.
Wardle et al. (2015) explained that targeting clinicians with education was an
effective means to optimize screening among individuals at risk for cancer. Similarly,
Saei Ghare Naz et al. (2018), in a systematic review, found that patient-based education
was among the most effective methods in modifying cervical cancer screening behavior
of women. Educational programs geared toward practitioners were identified as effective
in increasing patients’ awareness of the risks for PCa and the benefits of routine
screening (Rice et al., 2017). Programs designed to educate AAs about the need for PCa
screening have the potential to increase their awareness and compliance. Through
developing an evidence-based clinical practice patient education guideline (CPPEG)
related to PCa screening practices in AA men, I have provided a tool to better prepare
practitioners to educate the population with ethnically sensitive information. Nurses
working in the community clinic and any other setting can use the CPPEG to better
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educate AA men to make informed decisions in their care. Becoming more aware of the
benefits of PCa screening should increase knowledge and screening rates; increased
screening for PCa in AA men should produce a positive cultural transformation, ideally
leading to a decrease in the disparity by leading to earlier diagnosis and treatment, quality
care, and improved health outcomes and quality of life.
Problem Statement
PCa is the second leading cause of male deaths in the United States (Siegel et al.,
2020); the American Cancer Society (ACS, 2019) estimated that more than 202,000 men
have PCa, of which over 73,000 are expected to die from the disease. According to the
ACS (2016), Florida ranks second among all states in the United States for estimated new
cases of PCa and second in estimated deaths from the disease. In Florida, AA men
continue to face disparities in diagnosis, mortality rates, and access to cancer treatment.
According to Healthy People 2020, AA men in Florida were the only group that did not
meet the objective of reducing the death rate among the population from 21.2 per 100,000
men. Among males diagnosed with PCa in the United States, AA men are overrepresented, with AA men twice as likely to be diagnosed and die from PCa as their nonHispanic White counterparts (Shenoy et al., 2016). In 2019, an estimated 30,000 cases of
PCa were diagnosed in AA men, accounting for 30% of all cancers diagnosed in this
group. The lifetime risk of diagnosing PCa is 15.9%, while the lifetime risk of death is
2.8%. PCa incidence is 60% higher in AA men than in Whites. Furthermore, mortality is
double in AA men compared to Whites. AA men are collectively observed to have the
shortest rate of survival and highest death incidences from most cancers in the United
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States compared to all other population groups. The high incidence of PCa in AAs has,
for more than 20 years, remained remarkably constant (Tsodivoc et al., 2017).
Through this CPPEG project, I have developed a tool that all practitioners can use
to educate AA men with the intention of increasing PCa screening among this vulnerable
group. The ACS (2020) has published guidelines that recommend that men begin
screening for PCa at age 50 years; however, AAs and others with a high risk should begin
at age 45. The screening involves checking prostate-specific antigen (PSA) levels and
having a digital rectal exam (DRE) routinely. All men need to be educated on how to
recognize the signs of PCa, what a DRE is, what a prostate biopsy entails and when it
would be recommended, and interpretation of the PSA results (ACS, 2020). AA men
need education tailored to them because they have potential cultural, socioeconomic, and
healthcare access barriers (Cobran et al., 2018) that could cause reluctance to be
screened. Hahn et al. (2015) found that members of the AA population, in many
situations, only become aware of PCa when a close friend or relative is affected by the
disease. Many men are not aware of the interlink between race and the prevalence of PCa
or even the interlink between age and the onset of PCa. Another fact that many AA men
are not aware of is the possibility of PCa being asymptomatic.
Because of AA men’s vulnerability and reluctance to be screened, education is
needed to address common barriers, including stigma, the body part that is affected,
related embarrassment, and fear of the procedure (Shenoy et al., 2016).
Dickey et al. (2017) supported this need in a study that focused on AA men over the age
of 40 who had previously had PCa screening even though not previously diagnosed with
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the disease. The study findings revealed that participants who received education showed
increased participation in screening tests by approximately 21.4%. Another study by
Ukoli et al. (2013), also studying PCa education and screening among AA men, showed
that education interventions increased knowledge about PCa among AA men; screening
test rates rose from 49% to 71%. For high-quality patient education tailored toward the
targeted community, AAs, culturally sensitive, evidence-based guidelines should be
available. The lack of evidence-based, culturally sensitive education materials was a gap
in practice that I addressed by developing the CPPEG. Culturally sensitive education has
the potential to increase AAs’ participation in getting screened and decreasing mortality
from PCa (Ukoli et al., 2013). Although providers may be aware of new PCa screening
guidelines, they may lack the knowledge or tools to educate AA men facing screening
decisions about how best to proceed. Through this project, I have brought awareness of
the need for culturally sensitive patient education as well as provided a culturally
sensitive education tool related to AAs and PCa.
Purpose Statement
Practitioners are at the forefront of efforts to promote healthy behaviors, and there
is a lack of evidence-based teaching guidelines to assist practitioners in educating AA
men about PCa screening (Hoffman, 2020). AA males lack awareness of the importance
of or need for PCa screening, despite the availability of such screening. Many AA males
have negative attitudes toward annual routine checkups and limited knowledge and
skewed perceptions of PCa screening (Hahn et al., 2015). Hence, the practice-focused
questions that guided this PCa in AA men project were the following: What evidence
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from the literature supports the need for patient education related to PCa screening in AA
men? Can a CPPEG be developed and validated to guide nurses in educating AA men on
the importance of PCa screening? My goal was to provide a culturally sensitive guideline
for all practitioners with relevant information needed to prepare AA men to make
informed decisions about PCa screening with the potential to increase compliance with
screening and early treatment. AA men are at a higher risk of developing and dying from
PCa due to disparities in biological factors such as tumor biology; environmental factors
such as exposure to cancer-causing pollutants; and lifestyle factors such as social stress,
diet, body weight, physical activity, and smoking (Mucci et al., 2019). For this
demographic, the literature lacks clarity and specificity regarding how one should
structure an educational plan at the provider level to meet the AA male’s unique needs.
Hence, there was a need for this Doctor of Nursing Practice (DNP) CPPEG project, PCa
in AA Men, designed to increase providers’ knowledge of how to increase knowledge
about PCa screening among AA men, with the hope of increasing screening and
decreasing death rates.
Education has been shown to be effective in changing individuals’ attitudes
regarding their lifestyles and health practices (Hahn et al., 2015). For example, following
education campaigns, mammogram screening increased from 31% to 56% (Tataro et al.,
2020); cervical cancer screening improved in five African states (Ebu et al., 2019); and
education was found to be successful in increasing cancer screening among Korean
American men (Peterson et al., 2018). AA men are often reluctant to visit doctors, or they
may have misconceptions and misinformation that hinder them from seeking medical
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attention for early detection of PCa; thus, culturally sensitive educational materials are
needed. This CPPEG addressed the need for comprehensive, culturally based education
guidelines for providers to share with AA men to change their perceptions.
Nature of the Doctoral Project
Evidence for the PCa in AA Men project was obtained from an exhaustive
literature search that I continued until the newly developed CPPEG was revised and
approved by an expert panel, which included a nurse practitioner, an oncologist, an
oncology nurse with her MSN, and a primary care nurse practitioner. The Walden
University library databases EBSCO host, ProQuest Direct, Cumulative Index to Nursing
and Allied Health Literature (CINAHL), Google Scholar, PubMed, and Medline Plus,
along with Open Library and SpringerLink, were used to find up-to-date, peer-reviewed
articles related to PCa and AAs’ beliefs and responses. Search terms that I used included
PCa, AA, disparities, and educational guidelines for PCa teaching. I ensured relevancy to
the topic of AA and PCa by reviewing abstracts. This in-depth search for literature
related to AA men and PCa provided me with the most current evidence on the state of
the research and how best to address the gap that was the focus for this project.
Approach
The Walden University Clinical Practice Guideline Manual and the Appraisal of
Guidelines for Research and Evaluation (AGREE) II tool (AGREE Enterprise, n.d.)
were the primary guides for addressing the procedural steps of this PCa in AA Men
project. Articles selected to help address the gap of AAs not going for PCa screening
were obtained from peer-reviewed journals from the Walden library database, published
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within the last 5 years unless they were landmark studies, and organized in a literature
matrix. I graded the evidence using the Fineout-Overholt (2011) grading system (see
Appendix B). The AGREE II tool (AGREE Enterprise, n.d.) was used to guide the
development and evaluation of the CPPEG. The AGREE II tool is a valid and reliable
framework that is used to evaluate the veracity and quality of newly developed
guidelines.
In line with the Clinical Practice Guideline Manual, I developed my practicefocused questions and determined my evidence selection criteria. I developed an
evidence-based CPPEG based on the literature discovered in the in-depth literature
search. An expert panel of four members was identified to include a nurse practitioner,
an oncologist, an oncology nurse with her MSN, and a primary care nurse practitioner to
evaluate the newly developed CPPEG. Revisions of the guidelines were made based on
the recommendations of the expert panel until consensus was reached. Next, a group of
key stakeholders (practitioners who care for AA males) was identified and asked to
review the newly developed CPPEG for content and usability. I developed a final report
and shared it with the expert panel and stakeholders. After I graduate and the restrictions
of the pandemic are lifted, I will present the guidelines to related practices in the area
and present at local, regional, and national venues to share the tool for widespread use.
According to Owens et al. (2019), there is a need to identify some of the most effective
methods of promoting PCa awareness among AA men.
The purpose of this DNP project, PCa in AA men, was to develop a CPPEG to
bridge the gap in practice by providing resources to providers to educate AAs on the
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importance of PCa screening with an ethnically appropriate teaching tool. Providers are
often the first access point for health care in the United States; it is imperative to
comprehend what mechanisms may underlie the differences between AAs and other
populations and what can be done to narrow the gap (Tsodikov, 2017). Early screening
for PCa is an effective method of decreasing mortality and morbidity, in that a 5%
increase in the rate of screening PCa can avert about 500 related deaths per year
(Tsodikov, 2017).
Significance
This CPPEG will impact several stakeholders and organizations, including
hospitals, nurses, and patients. Addressing PCa among AA men will benefit the
community’s health and improve the livelihood of its members. The main positive impact
that this project will have on an organization level is financial stability from increased
reimbursement related to better patient outcomes. A nurse’s role in PCa awareness,
prevention, diagnosis, and treatment is essential. Nurses will be impacted by increased
job satisfaction due to the significant impact that they will have in helping AAs make
informed decisions in their care. The American Nurses Association (2018) noted a 25%
increase in nurse job satisfaction over a 2-year span linked with an overall quality of care
increase between 5% and 20% due to educating patients in making informed decisions.
Nurses will also have the tools necessary to educate AA men to more effectively dispel
many myths related to prostate screening.
Patients will be affected by having increased knowledge about the benefits of
prostate screening, better enabling them to make an informed decision about their care
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and improve their quality of life. According to Reynolds (2008), educational programs
associated with PCa will benefit patients by dispelling misconceptions, with medical
practitioners playing an important role in the process. The aim of this DNP PCa in AA
Men project was to provide resources to all providers involved in the care of AA men so
that they would be better equipped to educate these men to raise awareness of the prostate
screening process, leading to early diagnosis, intervention, and improved patient
outcomes, thus lessening disparity and decreasing mortality and morbidity among the
population.
This newly developed CPPEG is transferable to multiple practice areas such as
doctors’ offices, clinics, and all healthcare settings where AA men are treated, as the
myths and mistrust are global (Shenoy et al., 2016). The end product of the project
provides an educational approach for practitioners that is culturally appropriate and
tailored to AA men to address the unique needs for this group related to PCa. This
CPPEG will need to be tailored to apply the guideline to any other population or disease
process, addressing the specifics of the disease process and ethnic needs of the target
group. While the importance of PCa screening is universal, the AA population has unique
fears and beliefs to be addressed to improve their screening rates and decrease the
disparity that this vulnerable group faces with regard to PCa. AA men have higher
mortality rates from PCa than any other ethnicity (Shenoy et al., 2016).
The positive social change that a CPPEG to address PCa in AA men will bring
about is an increase in knowledge related to PCa screening, which should eventually lead
to earlier diagnosis and treatment, better patient outcomes, and improved quality of life,
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mirroring Walden University’s mission to improve human conditions through educational
resources. The integrated theory of behavior change (Ryan, 2009) indicates that health
behavior change can be improved by promoting knowledge and beliefs, increasing selfregulation skills and abilities, and enhancing social facilitation. According to Hoffman
(2020), early PCa screening has benefits of reducing the effects of the disease, especially
for men who are at risk for advanced stages of PCa. Some men are motivated to be
screened when they learn that early detection of PCa can improve their survival and
prevent some of the life changes that will impede a full, healthy life (James et al., 2017).
Summary
This section well defined the problem statement that AA men lack awareness of
the importance of or need for PCa screening despite the availability of such screening.
Subsequently, my project approach was to develop a CPPEG as a guide for providers to
educate AA men on screening methods and the importance of attaining screening. My
purpose statement exposed the gap in practice for this project, which was the lack of
educational resources for AA men about the benefits of PCa screening. This project is
anticipated to have a positive impact on the target population by providing enhanced
teaching resources for providers and improved health outcomes for AA men. In Section
2, I will discuss the context of the project, the model selected to guide this project, and
my role as a DNP student.
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Section 2: Background and Context
PCa is reported to be the second highest cause of male deaths in the United States
(Siegel et al., 2020), with AAs disproportionately affected relative to other ethnic groups
and twice as likely to die from the disease (Shenoy et al., 2016). Screening is crucial to
detect PCa at an early stage to optimize treatment and recovery (Tsodikov et al., 2017).
Therefore, the practice-focused questions for this project were as follows: What evidence
from the literature supports the need for patient education related to PCa screening in AA
men? and Can a CPPEG be developed and validated for PCa screening in AA men to
effectively increase screening rates? Through this DNP PCa in AA men project, my
purpose was to develop an evidence-based CPPEG to guide clinicians when educating
AA men about the methods and importance of PCa screening. In this section, I will
describe the AGREE II model that was used to guide this project, as well as address the
relevance of the project to nursing practice and my role as a DNP student in the
development of this project.
Models
The AGREE II tool was used to guide and validate the newly developed CPPEG.
The AGREE II instrument is currently the most applied and comprehensively validated
guideline appraisal tool worldwide (Brouwers et al., 2010) and is a standard guide that
can be applied to guidelines in any disease area targeting any step in the health care
continuum, including those for health promotion, public health, screening, diagnosis,
treatment, or interventions (AGREE Enterprise, n.d.). The AGREE II model has been
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used to guide the development of evidence-based practice guidelines as well as future
research in clinical practice recommendations (Shallwani et al., 2019).
Hoffmann-Eßer et al. (2018) reported that the main quality domains that the tool
addresses include the scope and purpose of the teaching, stakeholders’ involvement, and
the rigor of development for those involved. Other priority domains in the process are
clarity in presentation, applicability, and editorial independence. The AGREE II model
has been used in various studies, including Shallwani et al.’s (2019) assessment of the
strengths of and needed improvements to current guidelines being implemented for
physical activity or exercise recommendations for people with cancer. Wang et al. (2019)
recommended using the AGREE II tool to make improvements and strengthen specific
guidelines for nonvariceal upper gastrointestinal bleeding.
Relevance to Nursing Practice
PCa is the second leading cause of death in men in the United States, with PCa
incidence in AA men around 60% higher and death rates 2 or 3 times higher than in
Caucasian men (Shenoy et al., 2016). Shenoy et al. (2016) reported a 90% 5-year survival
rate for PCa if a prostate tumor is detected early, compared to only 35% for more
advanced disease stages. Black men comprise a high-risk group for PCa whose members
may profit from precautionary screening for early detection of PCa.
The ACS (2020) has published guidelines that recommend that men at age 50
begin screening for PCa, but AAs and others in high-risk groups should begin screening
at age 45; according to He and Mullins (2017), screening at as early as 40 years of age
has the benefit of early diagnosis for PCa. Research has shown that the earlier the
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detection, the better chance of survival for the patient (Tsodikov et al., 2017). There is no
definitive explanation for the disparity in PCa between AAs and non-Hispanic Whites;
however, He and Mullins (2017) hypothesized that a genetic difference, a clinical
difference in the course of the disease, social barriers, and poor access to healthcare were
responsible. Furthermore, Cobran et al. (2018), in their study of AA and Caribbean men,
found other reasons for not visiting doctors, such as family history, lack of health
insurance, misconceptions about how prostate screening is done, and misinformation
from healthcare providers about when to screen. Advanced metastatic PCa occurs at a
ratio of 4:1 in AA men and White men, respectively (Shenoy et al., 2016). The disease
transforms early from an indolent to aggressive state in Black men. The need to address
PCa among AA men is more obvious with the expanding rate among AA men despite the
registered decline in White men’s mortality rates (Cobran et al., 2018).
The differences in the disease course and differences in social issues that
disproportionately affect AA men place a greater health burden on these patients than the
rest of the population; hence, early diagnosis may improve overall health outcomes. The
U.S Preventive Services Task Force needs to adequately take into consideration
racial/ethnic differences when issuing screening guidelines (Shenoy et al., 2016).
Establishing separate screening guidelines for men of AA ancestry would help facilitate
earlier diagnosis and reduce mortality from the disease. Rice et al. (2017) studied the
impact of educational interventions on the risk of PCa with AA men between the ages of
18 and 75, finding that education can increase AA men’s understanding of the risk of the
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disease and increase their participation in screening. Educational interventions must focus
on the main apprehensions of those targeted to enhance prostate screening.
The ACS (2020) has published guideline recommendations for PCa screening, but
AAs and other high-risk groups need more targeted education to address barriers. The
ACS developed a PCa pamphlet and toolkit in 2019 consisting of an easy-to-read
informational flyer translated in 12 different languages that included promotional
activities to be used within any organization as well as short messages and helpful
resources about PCa screening. Though informative, these resources need to be tailored
for the AA population. The gap in practice that has been identified is a lack of
educational resources for AA men about the benefits of PCa screening. Despite
remarkable gains in overall life expectancy among other ethnic groups, life expectancy
for AA men remains the same; specifically, life expectancy for Caucasian men is 74
years and for AA men is 66 years (ACS, 2020). The disparity in life expectancy for AA
men is disproportionate due to an excess in cancer incidences, so educating them on the
importance of PCa screening to decrease the disparity is essential.
Local Background and Context
Although this project addressed no specific institution, the expert panelists came
from my surrounding community and work-related peers. According to ACS (2020),
41,000 American men die of PCa each year, with approximately 65% of this population
consisting of AAs. The mortality rate from PCa among AA men is more than double that
for Whites, with age-adjusted mortality rates of 64 per 100,000 and 26 per 100,000,
respectively (ACS, 2020). The disparity in PCa mortality rates is more distinct in the
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southeastern United States, where deaths from PCa among AAs happen at nearly 3 times
the national mortality rate for Whites. PCa screenings can provide earlier diagnoses,
ultimately improving opportunities for successful treatment and decreasing mortality. The
literature indicates that with preventive screening, AA men will be more aware of their
prostate health and hence take more precautionary measures (ACS, 2020). AA men must
be informed of the need to undergo screening and have fears and myths addressed.
The myths and stigma associated with PCa among AAs are widespread. Likewise,
the need for culturally based education is widespread; thus, this CPPEG will be
appropriate for all providers who treat AA men. The evidence-based teaching guideline
to educate AA men on PCa screening should, over time, decrease morbidity and mortality
among the population through early diagnosis and treatment of the disease.
Professional Organizations and Florida State Initiative Reviews
U.S. health organizations have declared that PCa screening, like other related
cancer screenings, requires education and counseling so that patients are well-informed
about the risks and benefits of screening and make informed decisions about their own
healthcare. In 2018, the American Academy of Family Physicians issued updated clinical
preventive service recommendations on PSA-based screening for PCa for AA men, based
on examination of multiple evidence reviews by the U.S. Preventive Services Task Force
to create its final statement of recommendation on PSA screening. Even with these new
guidelines, screening rates among AA men remain low while the PCa prevalence among
AA males is about 60% higher and the rate of mortality is about 3 times higher than in
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Caucasians (Tsodikov et al., 2017). Therefore, developing separate evidence-based
guidelines for AA men should reduce the PCa burden among the AA population.
The Florida PCa Advisory Council is a collaborative, multi-institutional,
interdisciplinary advisory body that has established a communication platform between
PCa stakeholders within the State of Florida by providing informational resources that
validate and disseminate PCa information (Gupta et al., 2015). The Florida PCa Advisory
Council’s mission is to make reliable information resources about PCa screening
accessible to patients, advocates, physicians, care providers, researchers, and Florida’s
governing officials about the need for prostate screening. The World Health Organization
(WHO) promotes and emphasizes cancer prevention to improve quality of life. According
to WHO, 30%-50% of cancer’s risk factors are due to unhealthy lifestyle practices such
as poor nutrition, smoking, and lack of exercise. Men of African descent have the highest
rate of PCa compared to all other ethnicities (Tsodikov et al., 2017). Therefore, educating
the AA population about the importance of prostate screening and preventative measures
can help in increasing screening rates and decreasing the disease among this vulnerable
group. This PCa in AA Men project provided educational resources for AA men about
the methods and benefits of PCa screening along with facts about the disease, thus
dispelling myths, addressing fears, and closing the gap in practice.
Role of the DNP Student
My professional context with PCa derived from my years of experience working
on an oncology floor. In this DNP PCa in AA Men project, I functioned as the leader.
Using Walden University's Clinical Practice Guideline Manual and the AGREE II tool
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as guides, I developed an evidence-based CPPEG using current, evidence-based sources
obtained through an exhaustive literature review. I selected a group of content experts
who reviewed the newly developed CPPEG using the AGREE II tool. No revisions were
needed, or recommendations were made, and the newly developed CPPEG was sent to
the end users (providers in the community who care for AA males) to assess for content
and useability; they agreed that the newly developed guideline was pertinent, well
written, and all-inclusive and would be easy to use.
My motivation for this project came from my father, who had PCa and died 2
years ago from the disease. With increased knowledge, my father might have been
screened and sought treatment earlier, resulting in a better outcome. I understand that I
may be biased as to the content that is included in the CPPEG, based on my personal
experience; however, I have minimized my biases by developing the CPPEG in concert
with the current evidence-based literature and information from organizational sites,
avoiding my personal opinion.
Summary
With statistics showing increased deaths and lack of prostate screening among
AA men compared to their counterparts, a separate educational evidence-based guideline
was needed to address cultural myths and barriers that deter this vulnerable group from
receiving prostate screening, thus decreasing the disparity. My DNP PCa in AA Men
project has provided providers with culturally sensitive, evidence-based guidelines to
educate AA men and increase their awareness of PCa screening for more extended life
opportunities. The project was guided by the AGREE II model, and the CPPEG was
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developed from an extensive evidence-based literature search. In Section 3, I discuss the
collection and analysis of evidence and my practice-focused questions.
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Section 3: Collection and Analysis of Evidence
The burden of cancer affects all populations across the world. AA men are a
minority community in the United States, and unwittingly they have more reported cases
of PCa than their peers; research shows that AA men are 1.6 times more likely to have a
positive PCa diagnosis and twice as likely to die from it (Bowen, 2018). Factors such as
lack of screening, nutrition, sedentary lifestyle, family history, and race (Shenoy et al.,
2016) play a role in causing the disparity. There are many contributing factors, but
prostate screening is recommended as a preventive measure to ensure early detection and
treatment.
The problem identified for this DNP PCa in AA Men project was the lack of
screening among AA men despite the availability of such. I have developed a CPPEG to
assist providers in educating AA men about the importance of PCa screening and
addressing ethnic beliefs and barriers such as cultural and socioeconomic factors and
poor healthcare access. Educational programs geared toward practitioners have been
shown to be effective in bringing awareness of the risk for PCa and the benefits of
screening. In this section, I discuss the practice-focused questions, the sources of
evidence, and a relationship between the evidence and the purpose. The collection and
analysis of evidence used to address the practice problem are described.
Practice-Focused Questions
The issue that I addressed in this evidence-based DNP PCa in AA Men project
was a lack awareness of the importance of or need for PCa screening in AA men despite
the availability of such screening. The gap in practice identified was the lack of
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educational resources for practitioners to use when educating AA men about the benefits
of PCa screening. Lack of educational resources creates a concern because AA men have
limited knowledge and skewed perceptions of PCa screening in addition to negative
attitudes toward annual routine checkups (Hahn et al., 2015). Therefore, developing
culturally specific evidence-based guidelines for AA men should help to increase PCa
screening. Hence, the practice-focused questions that guided this PCa in AA Men project
were as follows: What evidence from the literature supports the need for patient
education related to PCa screening in AA men? Can a CPPEG be developed and
validated to guide nurses in educating AA men on the importance for PCa screening? The
purpose of the project was to develop an evidence-based CPPEG to assist providers when
educating AA men on the benefits of PCa and the risks and management of PCa so that
they are better prepared to make informed decisions in their care.
Sources of Evidence
The CPPEG was based on evidence from current, peer-reviewed, published
research discovered in an in-depth literature search of peer-reviewed articles published
within the last 5 years unless they were landmark studies. Guidelines from professional
organizations and the Florida Advisory Council were also incorporated. The literature
was organized in a literature matrix (see Appendix A) and graded using the hierarchy of
evidence from Fineout-Overholt et al. (2010; see Appendix B) with articles from all
except Level 2 (individual single random control trials) of the seven levels.
This evidence from the literature and recommendations from professional
organizations were used to develop the culturally sensitive CPPEG to assist providers
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with current, evidence-based tools to educate AA men on the pros and cons of PCa
screening. Including higher levels of literature to include systematic reviews of
randomized controlled trials added strength to the guideline. An additional source of
evidence collected through this project was the results of the AGREE II tool provided by
the content experts, which established the quality of the newly developed CPPEG, along
with feedback from the end users, the nurses, and the providers, who agreed that the tool
would be useful to teach AA men about the importance of PCa screening.
Evidence Generated for the Doctoral Project
Participants
Following recommendations of the AGREE II tool (AGREE Enterprise, n.d.),
each guideline was assessed by four appraisers, as this increased the reliability of the
assessment; the expert panel consisted of an oncology nurse educator, a nurse
practitioner, an oncologist, and an oncology nurse with their MSN. These members were
selected for their expertise in PCa, their knowledge in evidence-based guidelines, and the
fact that they could relate to the practice-focused questions because of the low numbers in
screening in the target population seen in their practices. In addition, their direct
interaction with this population was a plus. The end users, three providers from the
community, reviewed the guideline for content and usability.
Procedure
After an extensive literature search, I arranged the pertinent articles in a literature
matrix and graded the evidence using criteria from Fineout-Overholt (2010). From this
current, evidence-based literature, I developed a culturally sensitive CPPEG (see
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Appendix E) and mailed a packet consisting of an introductory letter, the CPPEG, the
literature matrix, a disclosure form, the AGREE II tool, the AGREE II tool scoring sheet
(see Appendix D), and a link to the AGREE site to the expert panelists. The expert panel
was asked to review the quality of the CPPEG using the AGREE II tool
(www.agreetrust.org) and provide feedback within 2 weeks. The expert panelists
reviewed the CPPEG, with no revisions requested or recommendations provided. The
CPPEG was then presented to four end users (providers and nurses) who were asked to
review it and provide feedback on content and usability. I developed a final report and
shared it with the expert panel. After graduation, I will share the newly developed CPG
with administrators in the surrounding area for consideration of adoption, at which time I
will present the CPPEG to the providers; for wider dissemination, I will present at local,
regional, and national organizations’ conferences, state board meetings, and community
clinics.
Protections
Approval from Walden University’s Institutional Review Board and the facility
were obtained after the proposal was accepted. No identifying information was collected
on the AGREE II website, ensuring that the reviews were anonymous. There were no
paper files as the evaluations were completed on the AGREE site. All electronic files will
be maintained on a password-protected computer that only I will have access to for 5
years and then deleted. The site name will be masked to maintain anonymity.
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Analysis and Synthesis
The AGREE website (www.agreetrust.org) was used for recording, tracking,
organizing, and analyzing the evidence. The panelists were instructed to enter their scores
through the website. The website analyzed the findings and developed a final report,
which was sent to me. I reviewed the findings; all scores were above the benchmark of
75%, and no recommendations were made, nor revisions needed. From the findings, I
developed a final report. As the AGREE website gathers no identifying data, all
responses were anonymous. Reviewing the end users’ comments, I included their
responses in the final report. Summary evaluations from the content experts were also
reviewed, providing me with an evaluation of the process, the project, and my leadership
throughout the process.
Summary
In summary, AA men are a minority community in the United States but have
more reported cases of PCa compared to other cultures. The factors linked to the higher
PCa incidence include nutrition, lack of screening, family history, race, and sedentary
lifestyle. Educational programs geared toward educating men on the importance of
having PCa screening can minimize PCa cases among AA men, but AA men are reluctant
to be screened. In this DNP PCa in AA Men project, I developed a CPPEG to guide
nurses and other providers in addressing the lack of PCa screening among AA men based
on peer-reviewed, published research from Walden Library. An expert panel used the
AGREE II tool to evaluate the CPPEG; no recommendations were made, and no
revisions were needed. I mailed the CPPEG to the end users to review the newly
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developed CPPEG for content and useability, receiving positive feedback from them. In
Section 4, I address the findings and recommendations based on the analyzed data.
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Section 4: Findings and Recommendations
The local problem identified for this DNP PCa in AA Men project was the lack of
screening among AA men despite the availability of such. The goal of PCa screening is to
reduce death among AA men. The gap in practice was the lack of educational resources
for AA men about the benefits of PCa screening. The practice-focused questions that
drove the project were the following: What evidence from the literature supports the need
for patient education related to PCa screening in AA men? Can a CPPEG be developed
and validated to guide nurses in educating AA men on the importance of PCa screening?
The purpose of the project was to develop an evidence-based CPPEG to guide
practitioners when educating AA men about the significance of PCa screening so that
they can make an informed decision about their care. The sources of evidence that were
used to develop this CPPEG were peer-reviewed articles found in the Walden library and
through professional organizations. The AGREE II instrument was used by the expert
panel to evaluate the newly developed CPPEG for rigor and clarity. The end users
evaluated the newly developed guidelines for content and usability, and the content
experts provided feedback on the process, the project, and my leadership through a
summary evaluation. In this section, I will discuss the findings and the implications,
recommendations, and strengths and limitations of the project.
Findings and Implications
After an in-depth review of the literature, a literature matrix was developed (see
Appendix A) by using pertinent articles that were graded using Melynk grading criteria.
Three Level 1 articles, two Level 3, one Level 4, six Level 5, two Level 6, and five Level
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7articles were selected for use in the development of the CPG. The vast number of peer
reviewed articles and numerous systematic reviews added strength to the CPPEG.
Four expert panelists provided evaluations of the newly developed CPPEG on the
AGREE II website. The evaluations addressed the 23 items from the six domains, with
scores for each domain above 75%. The threshold for high quality is scores above 50%
for each domain; however, any scores below 75% should be evaluated (AGREE
Enterprise, n.d.). Domain 1, scope and purpose scored 100%; Domain 2, stakeholder
involvement, scored 93%; Domain 3, rigour of development, scored 92%; Domain 4,
clarity of presentation, scored 100%; Domain 5, applicability, scored 90%; Domain 6,
editorial independence, scored 92%; and the overall appraisal score was 96% (see
Appendix D).
The reviewers only scored individuals from all the relevant professional groups
being included in the development of the CPG at 24/28; the variety in education and roles
of the reviewers addressed this requirement. Also questioned was the monitoring and/or
auditing criteria, which were clearly addressed at the end of the introduction with the
statement “the guideline should be reevaluated every 3 years or when new
recommendations for prostate screening in AAM are published.” Auditing is addressed in
the recommendations and evaluation of the project. One panelist commented that PCa in
AA men is a health issue that needs addressing with educational interventions, while
another appraiser commented that there is a demonstrated need for education and
culturally based care for the AA community.
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Two of the end users who were providers and nurses commented that the CPG
was well developed, clear, and concise and that it is a tool that is user friendly and likely
to make a change in how AAs are educated, addressing cultural issues and concerns and
making them more knowledgeable about PCa screening, ideally improving quality of life
for AAs. Both the expert panelists and end users had never seen a CPG specific to AA
men and PCa screening, supporting the need for the project. The CPPEG is an evidencebased educational tool to guide providers in teaching AA men and better preparing them
to make an informed decision about their care, fostering positive social change by
increasing PCa screening in this vulnerable group.
Recommendations
The gap in practice for this DNP project was the lack of educational resources for
AA men about the benefits of PCa screening. That gap was addressed by developing a
culturally sensitive, evidence-based guideline for providers to use for educating AA men
with appropriate knowledge to better equip them in making decisions regarding their care
based on knowledge gained through the education that they received on the importance of
prostate screening. There was no specific site for the project, but there are several sites
that I intend to share the guideline with after graduation; I will present the CPG to
administrators at doctors’ offices and community clinics for consideration of
implementation and then present the information to the nurses and providers. My desire is
that this newly developed CPPEG will make a difference in the lives of AA men.
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Strengths and Limitations of the Project
The focus of this DNP project was to fill the gap in practice, which was the lack
of educational resources for AA men about the benefits of PCa screening, by providing
nurses and providers with a culturally sensitive guide tailored to AA men. The end
product provides a ready resource of appropriate information needed to aid AA men in
making informed decisions regarding their care. One of the strengths of the newly
developed CPPEG was the amount of culturally relevant, evidence-based resources
available to be included in the newly developed guideline. The positive feedback
received from the expert panelists and their willingness to use this tool was another
strength. One of the appraisers commented that there is a demonstrated need for
education and culturally based care for AA men.
One of the limitations for this DNP project was that there was no set organization
affiliated with it due to the pandemic and associated restrictions; this will delay my
dissemination until the pandemic restrictions are lifted. Visiting these multiple sites is the
only way to have the newly developed CPPEG implemented. Another limitation was my
time constraints, as I am currently paying for this terminal degree out of pocket and I am
financially strained. In addition to financial obligations, family commitments have been
neglected due to work overload and sleepless nights to complete this terminal degree.
The review of the available literature provided me with valuable knowledge that I
will use throughout my career. I feel better prepared to be a spokesperson for the
prevention and early diagnosis of PCa, especially in AA men. I am also more aware of
the barriers that AAs and other minority groups face in receiving quality health care.
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These barriers, myths, and fears are all areas that I hope to address in future projects.
After my newly developed CPPEG is implemented, I will lead the facilities in evaluating
the implementation, comparing screening rates, and, over time, reducing the incidence of
PCa in the AA population. Seeing positive changes should further support the validity of
the CPPEG.
Summary
The findings and implications for this project were centered around the expert
panelists’ evaluation using the AGREE II instrument. The panelists favored the CPPEG
and gave high scores in all six domains (see Appendix D). Their feedback on the need for
this culturally based educational intervention was paramount. The strength of this project
was that the gap in practice was addressed, and the differences between ethnicities in PCa
screening should be minimized due to providing a culturally sensitive, evidence-based
teaching tool to address the fears, myths, and misinformation that have been found to add
to the disparity for AA men regarding PCa. In Section 5, I will focus on my self-analysis
and summary of the final DNP project, including challenges, solutions, and insights
gained on the scholarly journey.
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Section 5: Dissemination
The implementation of this project will extend after graduation when I can present
the CPPEG to various organizations. I will share the newly developed CPPEG in doctors’
offices and community clinics where patients are often seen for their yearly or routine
visits. Urology and oncology clinics are other settings that I will approach, as they are the
referral sites for the population that this CPPEG will benefit. I plan to meet with
administrators and present my newly developed CPPEG to get authorization to offer it to
nurses and providers. I will highlight critical information to strengthen screening and
embrace a proactive approach toward PCa among AA men. Using a collaborative
approach to dispel myths and misconceptions surrounding PCa screening is vital (Shenoy
et al., 2016). PCa is widespread, and its occurrence is increasing among AA men.
Although providing the newly developed CPPEG in the surrounding community
will impact the local population, it is through publication and presentations at regional,
national, and global professional meetings that I will make the biggest impact. Therefore,
I will query pertinent journals, to include Clinical Journal of Oncology Nursing and
The Journal of the National Black Nurses Association, for consideration for publication
and submit an abstract to present the project at The Cancer Nursing conference.
Analysis of Self
I started my nursing career as a registered nurse on an oncology unit; I remember
saying to myself, “oh no, oncology,” but later it became a passion for me, especially after
my dad got diagnosed with and died from PCa. I found my passion for educating and
addressing the lack of PCa screening among AA men, which led me to pursue a master’s
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degree and then my terminal degree. I developed this CPPEG so that I can bring
awareness of and provide resources on the importance of prostate screening, especially to
AA men, by educating providers on how to educate AA men to make informed decisions
about their care.
Practitioner
As a DNP student carrying out this project, I was able to take on roles as
practitioner, scholar, and project manager. In the role of practitioner, I was able to use my
educational background and clinical expertise to review evidence-based practice
guidelines, identify the problem that the project was focused on, and develop a CPPEG
that nurses and providers will use to enhance the education provided to AA men. In this
role, I found that this was one of the ways that a DNP-prepared nurse fosters the bridging
of the gap of research and practice. As a practitioner, one of my strengths was my ability
to research the literature and find meaningful articles for this project; however, one of my
weaknesses was accurately applying the appropriate grade level to each article in relation
to the literature matrix, which required me to seek assistance from the Walden Library
and my peers. To minimize this weakness, I spent time deciphering the actual grading
tool for similarities between grading Level 1 and Level 7 articles.
Cultural differences do affect health beliefs and patient education; therefore,
addressing these disparities will positively impact outcomes and enhance learning in the
target population. My long-term goal is to find a full-time academic position in the
nursing department in a university and to be the spokesperson for culturally sensitive
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educational interventions and educating the AA male population about the need for PCa
screening.
Scholar
The road to my DNP has been filled with great experiences—experiences of both
joy and sadness as my father passed away from PCa before I could complete this terminal
degree. As a scholar, I focused on my courses and learning everything possible. In
reflecting on my journey, I have learned to look at what it takes to be a scholar in a
different light, such as the ability to research and break down the elements into usable
components that nurses can use to improve nursing care. I was able to identify and
overcome many challenges (personal and professional), which I had to navigate
sometimes single-handedly, to be able to be at this juncture. The education obtained has
solidified the many aspects of integrating changes within the nursing sector that will align
with current healthcare legislation recommendations as it pertains to evidence-based
research. In my professional career, I have advanced by sitting on committees to
implement changes to patient care aligned with evidence-based practice through research.
Additionally, I have aided in implementing patient safety policies through data analyses
to identify patient safety issues using evidence-based interventions, demonstrating that a
new approach will lead to improved quality and patient safety. My long-term professional
goal is to find an adjunct faculty position teaching online and continue working as an
advanced practice registered nurse.
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Project Manager
Being a project manager was stressful, as I did not know anything about the
AGREE II website. I was fortunate that three of my expert panelists were familiar with
the website, but I had to be familiar with the site so that I could aid the other expert
panelist. This was a tedious, even stressful, task for me. As it was my first time
encountering the AGREE II website, I had to reach out to my peers for guidance on how
to navigate the site. However, the end product, the newly developed CPPEG for nurses
and providers, gave me a sense of fulfillment, knowing that providers would now have
access to an evidence-based guideline specific to AA men for teaching them about PCa
screening and addressing culturally sensitive barriers.
Challenges, Solutions, Insights Gained
The challenges that I faced during this process were personal and academic.
Completing some of the core courses was extremely challenging for me, as some courses
lacked clarity and I had to keep reaching out to the professor for assistance; sometimes,
the clarification took 2 to 3 business days or even longer, which increased my anxiety
even more. I was not aware that while working on the core courses I could have initiated
the proposal. While working on my project, my father passed away from PCa, which led
me to take a semester off. However, the greatest challenges that I faced were the
revisions of this scholarly project; another challenge was learning how to navigate the
AGREE website to aid the panelists who had no knowledge of the site.
I have gained new insights on the importance of seeking early guidance—for
example, how to write in the template instead of creating a new document with each
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revision, which would have fostered a quicker completion of my DNP project. Other
personal obligations, including taking care of family responsibilities and working while
trying to complete school, were very demanding. The biggest academic challenges that I
faced were making the necessary revisions and doing the literature matrix. In addition,
trying to understand the AGREE II tool was not an easy task to accomplish. The
completion of this project has provided me the opportunity to gain further insights about
myself and the profession of nursing. I have a better understanding of the importance of
the DNP role as it relates to converting evidence-based information into evidence-based
practice. Finally, through this role, I can make a difference in the lives of patients, nurses,
and providers, ensuring that clinical practices are based on scientific methodologies.
Summary
PCa is significant disease that impacts men globally, but with an excellent
survival rate when it is detected early. AA men are 50% more likely to develop and die
from PCa compared to men of another ethnicity. They have the lowest rate of prostate
screening when screening is readily available. The purpose of this doctoral project was to
develop a CPPEG for nurses and providers to use to educate AA men on the importance
of prostate screening. The supporting literature supported the need for nurses to know the
significance of culturally related barriers that AA men have related to PCa. The
implementation of the newly developed CPPEG will fill the gap of not having a
standardized, culturally sensitive educational teaching tool. Working through endless
challenges of writing the guideline and having an appraisal completed by a diverse panel
of experts was a task like no other I have done before. The creation of this CPPEG
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afforded me the latitude of providing other healthcare practitioners a CPPEG that is
grounded in scientific underpinnings. Culturally sensitive education will always be
imperative, and it is one of my responsibilities, as an advanced nurse practitioner, to
assist nurses and clients in promoting and enhancing quality individual care. Finally, the
evaluations from the expert panelists reinforced that this newly developed evidence-based
CPPEG should positively impact nurses’ and patients’ knowledge when it comes to
educating and performing self-care practices toward self-screening for PCa, decreasing
the burden that AA men face due to lack of prostate screening.
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Note. Evidence graded using the hierarchy of evidence model from “Evidence-based Practice Step by Step:
Critical appraisal of the evidence: Part I,” by E. Fineout-Overholt , B. M. Melnyk, S. B Stillwell, and K. M
Williamson, 2010, American Journal of Nursing, 110(7), p.47-52.
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Appendix B: Melynk and Fineout’s (2011) Levels of Evidence

Adapted from Melnyk & Fineout-Overholt’s (2011) model.
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Appendix C: AGREE II Instrument
Domain 1. Scope and Purpose
1. The overall objective(s) of the guideline is (are) specifically described.
2. The health question(s) covered by the guideline is (are) specifically described.
3. The population (patients, public, etc.) to whom the guideline is meant to apply
is specifically described.
Domain 2. Stakeholder Involvement
4. The guideline development group includes individuals from all the relevant
professional groups.
5. The views and preferences of the target population (patients, public, etc.) have
been sought.
6. The target users of the guideline are clearly defined.
Domain 3. Rigor of Development
7. Systematic methods were used to search for evidence.
8. The criteria for selecting the evidence are clearly described.
9. The strengths and limitations of the body of evidence are clearly described.
10. The methods for formulating the recommendations are clearly described.
11. The health benefits, side effects, and risks have been considered in
formulating the recommendations.
12. There is an explicit link between the recommendations and the supporting
evidence.
13. The guideline has been externally reviewed by experts prior to its publication.
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14. A procedure for updating the guideline is provided.
Domain 4. Clarity of Presentation
15. The recommendations are specific and unambiguous.
16. The different options for management of the condition or health issue are
clearly presented.
17. Key recommendations are easily identifiable.
Domain 5. Applicability
18. The guideline describes facilitators and barriers to its application.
20. The guideline provides advice or tools on how the recommendations can be
put into practice.
21. The potential resource implications of applying the recommendations have
been considered.
22. The guideline presents monitoring or auditing criteria.
Domain 6. Editorial Independence
23. The views of the funding body have not influenced the content of the
guideline.
24. Competing interests of guideline development group members have been
recorded and addressed.

52
Appendix D: AGREE II Scores

A critical group appraisal of:
Clinical Practice Guideline
using the AGREE II Instrument
Created with the AGREE II Online Guideline Appraisal Tool.
No endorsement of the content of this document by the AGREE Research Trust
should be implied.
Co-ordinator: Joain Silvera
Date: 30 July 2021
Email: joain.silvera@waldenu.edu
URL of this appraisal: http://www.agreetrust.org/group-appraisal/15094
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Guideline URL:

Domain Domain Domain Domain Domain Domain OA
1
2
3
4
5
6
1
100%

93%

92%

100%

90%

92%

Yes - 4, Yes with
96% modifications - 0,
No - 0

Domain 1. Scope and Purpose
Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4
Item 1

7

7

7

7

Item 2

7

7

7

7

Item 3

7

7

7

7

Domain 2. Stakeholder Involvement
Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4
Item 4

6

6

7

5

Item 5

6

7

7

7

Item 6

7

7

7

7

Domain 3. Rigour of Development
Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4
Item 7

6

7

7

6

Item 8

7

7

6

7

Item 9

6

6

7

5

Item 10 7

7

7

6

Item 11 7

7

7

7

Item 12 7

6

6

7

OA 2
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Item 13 6

6

6

7

Item 14 6

6

7

7

Domain 4. Clarity of Presentation
Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4
Item 15 7

7

7

7

Item 16 7

7

7

7

Item 17 7

7

7

7

Domain 5. Applicability
Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4
Item 18 6

6

6

7

Item 19 7

6

7

7

Item 20 7

7

7

6

Item 21 5

5

6

7

Domain 6. Editorial Independence
Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4
Item 22 7

6

6

7

Item 23 7

7

6

6

Overall Assessment
Appraiser 3 Appraiser 1 Appraiser 2 Appraiser 4
OA1

7

7

6

7

Created online at www.agreetrust.org 30 July 2021
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(a) Domain 1. Scope and Purpose
Item 1
•
•

Appraiser 3: Yes, the CPG was described in detail
Appraiser 4: Very well presented.

Item 2
•
•

Appraiser 3: Yes, the question described the issue at hand
Appraiser 4: Presented by candidate.

Item 3
•
•

Appraiser 3: Yes, African American men population
Appraiser 4: The population is identified, and description is noted.

(a) Domain 2. Stakeholder Involvement
Item 5
•

Appraiser 4: Clearly identified.

Item 6
•

Appraiser 3: Yes, nurses and providers

(b) Domain 3. Rigour of Development
Item 8
•

Appraiser 3: Yes, the evidence selecting African American men disparity
to prostate cancer was clear and concise

Item 9
•

Appraiser 4: Described
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(a) Domain 4. Clarity of Presentation
Item 15
•

Appraiser 4: Clearly defined

Item 16
•

Appraiser 4: Well, presented.

(b) Domain 5. Applicability
Item 18
•

Appraiser 4: Noted

Item 19
•

Appraiser 4: Recommendations noted

c) Domain 6. Editorial Independence

No comments found for this domain.

(c) Overall Assessment
•
•

Appraiser 3: Prostate cancer in African American men is a health issue
that needs addressing with educational intervention.
Appraiser 4: There is a demonstrated need for education and culturally
based care for the African American community. This guide minoritybased health disparities.

Created online at www.agreetrust.org 30 July 2021
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Appendix E: Teaching Guidelines for Screening Prostate Cancer
in African American Men (AAM)
Purpose:
To provide teaching guidelines to assist providers in educating AAM on the
importance of prostate cancer screening. This CPG will address the need for
comprehensive, culturally based education guidelines for providers to share with
AAM aged 40 and older to change their perceptions, with the intention of
increasing prostate screening among AAM.
Procedure:
• Education will start at the doctor’s office
o nurses will communicate the importance of prostate cancer screening at
the male’s annual well checkups.
• The nurse will:
o explain what prostate cancer is
o discuss signs and symptoms of prostate cancer
▪ explain how prostate cancer can be asymptomatic at times so
screening is essential
▪ discuss the potential risks of prostate cancer
▪ explain the benefits of prostate cancer screening
▪ discuss the meaning of a PSA test
▪ explain what a digital exam is
▪ Allow for discussion are questions related to the procedure
▪ Answer questions and clarify questions as needed
• The nurse will review information at every visit
Question:
What information specific to AAs do providers need to educate AAM, potentially
increasing screening and decreasing the disparity of morbidity and mortality from
prostate cancer?
Target Population:
AAM aged 40 and older due to the high-risk factors for being diagnosed prostate
cancer
Recommendations:
Prostate cancer is a significant health issue for AAM. It is essential to adequately
plan and implement educational interventions that target behaviors through
screening to reduce morbidity rates and raise awareness about the disease
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•
•
•
•
•

Because AAM are more vulnerable and reluctant to be screened
Wardle et al. (2015) explained that providing clinicians with education
was an effective means to optimize screening among individuals at risk for
cancer.
Educational programs geared towards practitioners were identified as
effective in increasing the patients’ awareness of the risk for prostate
cancer and the benefits of routine screening (Rice et al., 2017).
Screening as a preventive measure is recommended early and regularly to
ensure that early detection leads to effective treatment and recovery
(Tsodikov et al., 2017).
Routine screening has been touted to be the most effective strategy for
identifying prostate cancer in males (Van Hoof et al., 2018).

Key Evidence:
The American Cancer Society (ACS, 2019) estimated more than 202,000 men have
prostate cancer of which over 73,000 are expected to die from the disease.
• In 2019 an estimated 30,000 cases of prostate cancer were diagnosed in AAM.
• Prostate cancer is disproportionately higher in AAM compared to other ethnic
groups in the United States. Prostate cancer incidence is 60% higher in AAM
than white men.
• Mortality rate is double in AAM than white men.
• The high incidence of prostate cancer in AAM has remained remarkably
constant for more than 20 years (Tsodikov et al., 2017).
o The reason for such disparity is unclear but probably due to
socioeconomic factors such as race, family history, lack of education,
and health insurance (Shenoy et al., 2016).
• Culturally sensitive education has the potential to increase AAM participation
in getting screened and decreasing mortality from prostate cancer (Ukoli et al.,
2013).
Guideline Monitoring:
•
•

The guideline should be reevaluated every 3 years or when new recommendations
for prostate cancer screening in AAM are published.
Barriers to the application of this guideline should be addressed as they arise by
the providers and before application.

This Prostate Cancer in AAM project did not request or receive any funding for the
development of the CPPEG
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Teaching Guidelines for Screening Prostate Cancer in African American Men
This guideline is intended to increase knowledge about prostate screening among African
American men (AAM)
What is Prostate Cancer?
Prostate cancer is a type of tumor that occurs in the prostate, which is small
walnut-like shaped gland in males that functions to produce seminal fluid that
moves and nourishes sperms. The body part that is affected is the prostate gland.
The prostate gland is a part of the male reproductive system, between the penis
and the rectum, that secretes fluid to mix with semen during ejaculation.
•

Signs and symptoms of Prostate Cancer:
▪

Early prostate cancer may show no symptoms, but some patients may
experience

•

▪

difficulty voiding

▪

urinary retention

▪

pain in the hip, back, or bones

▪

constipation and/or blood in the urine or semen

Potential risk factor for prostate cancer:
▪

Age- the risk of prostate cancer increases with age, especially over the age
of 50
▪

With family member having prostate cancer
•

▪

begin screening at age 40

Race- Black men are diagnosed with prostate cancer more than men from
other ethnicities
▪

▪

Start annual screening by age 50

Socioeconomic status
▪

African American men are more likely to have a lower
socioeconomic status than other men.

▪

Low socioeconomic status has links to a higher chance of cancer
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▪

Low income
▪

financial barriers are a major contributor to prostate
cancer outcomes (Shenoy, et al, 2016).
▪

▪

provide easy access to providers

Lack of education
▪

provide easy to understand materials

▪

Cultural

▪

Health practices, illness beliefs, and behaviors are motivated by Black
men’s ideas about being macho or manly.
•

Generally, Black men are said to take pride in having and
maintaining a high level of wellness without needing to
consult a health care provider (Allen et al., 2007)
•

being ill threatens what it means to be a man

o Racial bias in health care•

AAM may face racial bias in healthcare due to the color of
their skin
•

Provider’s lack of understanding of how to converse
with AAM
▪

May avert treatment

▪

Less likely to be told about prostate
screening and prostate specific antigen test
(PSA) in preventive care compared to their
White counterparts.

▪

Family History
•

Having a relative with prostate cancer increases the risk of
developing the disease
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•

There is nothing to do to prevent it, but early
detection could save one’s life
▪

Talk to each patient about when to start
screening, based on their individual history

▪

All AAs, by the age of 50

▪

At least by the age of 40, with one family
member having prostate cancer

How is prostate cancer screening done?
•

PSA is a blood test which measures the amount of protein cells in the
body
o The body produces normal protein cells, as well as cancerous ones
which causes prostate cancer
o PSA levels of 4.0 ng/mL and lower are considered normal
▪

a PSA level above 4.0 ng/mL is considered abnormal
•

doctors would often recommend a
prostate biopsy to determine if prostate cancer is
present
o any inflammation or irritation of the prostate
can also cause an elevation

•

Digital exam
o providers insert a lubricated finger in the rectum to check for
swelling and inflammation
▪

this is uncomfortable and could be embarrassing, but is
necessary
•

The results would indicate an enlarged prostate,
abscesses, or rectal cancers

•

If abnormality is found the provider would indicate
further testing such as an ultrasound
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o a small probe inserted in the rectum to take a
picture of the prostate gland
•

A prostate biopsy will also be done
o a thin needle is inserted into the prostate to
collect tissue. The tissue sample is examined
in a lab to determine if cancer cells are
present

What are the benefits of prostate screening?
•

Screening for prostate cancers will help reduce the spreading of the cancer
▪

treatment before it spreads may lower the chance of death from prostate
cancer in some men

▪

Given the high risk of developing and dying from prostate cancer, AAM
are more likely to be saved by screening.

•

Screening consists of:

▪

a prostate specific antigen test (PSA)
▪
•

a blood test which measures the level of PSA in the blood.

digital rectal exam
▪

provider will insert a well lubricated finger in the rectum to check for
swelling and inflammation.
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PROSTATE CANCER SCREENING
Patient Education for the AA Male
What is Prostate Cancer?
Prostate cancer is a type of tumor that occurs in the prostate gland, which is a
small walnut-like shaped gland in males that functions to produce seminal fluid to
nourish and move sperm. The body part that is affected is the prostate gland. The
prostate gland is a part of the male reproductive system, between the penis and the
rectum, that secretes fluid to mix with semen during ejaculation.
•

Signs and symptoms of Prostate Cancer:
▪

Early prostate cancer may show no symptoms, but some patients may
experience

•

▪

difficulty urinating (passing water)

▪

urinary retention (unable to pass urine)

▪

pain in the hip, back, or bones

▪

constipation and/or blood in the urine or semen

Potential risk factor for prostate cancer:
▪ Age- the risk of prostate cancer increases with age, especially over the age
of 50
▪ Begin prostate screening by age 50
▪ With family member having prostate cancer
• begin screening at age 40
▪ Race- Black men are diagnosed with prostate cancer more than men from
other
groups
▪ Start annual screening by age 50, 40 if you have a family history
▪ Socioeconomic status
▪ Do you need help paying for your medicines?
• YES – see APPENDAGE A
▪ Do you have insurance?
• YES – see APPENDAGE B
▪ Cultural
▪ Health practices, illness beliefs, and behaviors are motivated by
Black men’s ideas about being macho or manly.
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▪

Access to healthcare
▪ Trouble finding a provider?
▪ Provider too far away?

• See APPENDAGE C
▪ Lack of transportation to provider?
• See APPENDAGE D
▪ Promote good health practices, at an early age that will promote
AAM to seek early medical attention
• See APPENDAGE E
How is prostate cancer screening done?
• PSA (prostate screening antigen) is a blood test that measures the
amount of a specific protein cells in your body produced by the body
o These can be normal cells or cancerous ones which cause prostate
cancer
o PSA levels of 4.0 ng/mL and lower are considered normal
▪ a PSA level above 4.0 ng/mL is considered abnormal
o any inflammation or irritation of the prostate
can also cause an elevation
• doctors would often recommend a
prostate biopsy to determine if prostate cancer is
present
• Digital exam
o Provider will insert a lubricated finger in the rectum to check for
swelling and inflammation
▪ this is uncomfortable and could be embarrassing, but is
necessary
• The results would indicate an enlarged prostate,
abscesses, or rectal cancers
• If abnormality is found the provider would indicate
further testing such as an ultrasound
o a small probe inserted in the rectum to take a
picture of the prostate gland
• A prostate biopsy will be done
o a thin needle is inserted into the prostate to
collect tissue. The tissue sample is examined
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in a lab to determine if cancer cells are
present
What are the benefits of prostate screening?
• Screening for prostate cancers will help reduce the spreading of the cancer
▪ treatment before it spreads may lower the chance of death from prostate
cancer in some men
▪ Given the high risk of developing and dying from prostate cancer, AAM
are more likely to be saved by screening.

Patient Signature _____________________________________Date________
Witness Signature ____________________________________Date________
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APPENDAGE A
Financial Concerns
If you need help paying for their medication:
• call your provider’s office to see if they have any medication
samples available
•

call your pharmacy to see if you are qualified for any patient
assistance program
o patients who meet certain criteria can receive their
medications for free or up to 80% paid for them

•

Contact the drug manufacturer (contact information often available
on the medicine bottle or on the internet)
o They often have financial assistance available for those
who qualify
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APPENDAGE B
Insurance Courage

No insurance?
• Talk to the case manager
o They may be able to help you find an affordable program
you qualify for
o They may be able to assist with paperwork
•

Call Medicaid
o

Provide number (1-877-711-3662)
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APPENDAGE C
Access to Providers
Trouble finding a provider?
•

Free community clinics:
o

Jackson Health System 305 585 xxxx

o Citrus Health System 305- 825 xxxx
o Jessie Trice Health System 305 637 xxxx
o Community Health of South Florida 786 293 xxxx
▪

These clinics provide assistance to patients with and
without insurance to obtain screening and also
provide wellness visit
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APPENDAGE D
Transportation
Lack of transportation to providers?
• Call your clinic
o some of the clinics provide free transportation, picking you
up at your home and bringing you to the clinic
•

Ask your provider’s office about telehealth
o Telehealth services are often available if you have access to
a phone or a computer
▪

you can see the physician from the comfort of your
home.
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APPENDAGE E
Health Practices
Begin good health practices that promote seeking early medical attention NOW:
•

includes healthy lifestyle, such as
o not smoking
▪

need help quitting?
•

ask your provider, help is available

o reduce alcohol drinking
▪

need help?
•

AA is free and available, ask your provider for
information

•

your minister often can provide resources

o reduce fatty foods
▪

a nutritionist is usually available through your provider
•

ask for a referral

o eat more fruits and vegetables
▪

a nutritionist is usually available through your provider

▪

does your community have a “free garden” ?

▪

do you qualify for grocery assistance?
•

ask for a referral

o maintain a healthy weight by exercising
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▪

exercise can reduce infection, improve immune function
and fight some of the negative health effects
•

many insurances cover gym membership or exercise
classes

•

You tube and Google have many free exercise tapes
o ask your provider for suggestions

